Cancer Treatment Centers of America

CTCA Breast Cancer Center in Tulsa

“We discuss each breast cancer case as a team, as part of our mission to treat our patients as individuals, and we are committed to developing treatment plans that fit their disease type, stage and other factors that make their cancer unique to them. We also integrate supportive care therapies into their care plan to help them manage side effects and improve their quality of life.”

Your treatment options

Because of the large number of options available today, breast cancer patients often face many decisions regarding their treatment. Our Breast Cancer Center experts help you navigate those options and choose a treatment plan designed to fit your needs. They are also committed to keeping you informed of new or emerging treatments that may be considered as part of your care plan.

Our oncologists are experienced in treating early-stage breast cancer, as well as more complex diseases, such as triple-negative, HER2-positive and inflammatory breast cancer. Depending on your cancer type, stage and goals, your treatment options may include surgical procedures, including breast conservation or microsurgical techniques. We also provide a variety of breast reconstruction options, such as nipple-sparing mastectomy and 3-D nipple tattoos. Other treatments may include chemotherapy, radiation therapy, targeted therapy and/or hormone therapy.

Quality of life

Conventional treatments plus supportive therapies
Because breast cancer treatments may cause disruptive side effects, including neuropathy, fatigue, appetite loss, pain or nausea, your care team may recommend a number of evidence-informed supportive therapies, such as nutrition therapy, naturopathic medicine, mind-body medicine, pain management, spiritual support and sexual wellness counseling. Our oncology rehabilitation team also helps patients manage side effects like lymphedema. Your team works together to design a plan to help you maintain your quality of life throughout treatment.

Learn more about how integrative cancer treatment may help you manage the cancer journey.

Our Breast Cancer Center doctors

The CTCA Breast Cancer Center in Tulsa is staffed by a team of doctors committed to providing comprehensive, personalized care for breast cancer patients. The center is led by Sagun Shrestha, MD. Board-certified and fellowship-trained, Dr. Shrestha also serves as the Medical Director of Pharmacy and Therapeutics and as Program Director of the Medical Oncology Fellowship program at our Tulsa hospital. She is a member of the American Society of Clinical Oncology, American Society of Hematology and American College of Physicians.

The Breast Cancer Center team also includes Medical Director of Surgery and Breast Surgery Michael Thomas, MD, FACS, Radiation Oncologist Douglas Kelly, MD, and Medical Director of Plastic and Reconstructive Surgery Rola Eid, DO, FACOS.

Dr. Thomas is a breast surgeon board certified in general surgery by the American Board of Surgery and is a Fellow of the American College of Surgeons. He also is a member of the American Society of Breast Surgeons, the American Medical Association and the Society of Laparoendoscopic Surgeons. Dr. Kelly is a radiation oncologist with expertise in multiple areas, including an advanced form of intensity modulated radiation therapy (IMRT) combined with computed tomography (CT) scanning technology, stereotactic radiosurgery technologies such as robotic radiosurgery systems, brachytherapy and breast conservation therapy, as well as other methods of partial breast irradiation. Dr. Eid, a plastic and reconstructive surgeon, has training in numerous plastic surgery techniques, including breast reconstruction and microsurgery. She is board certified in plastic and reconstructive surgery, as well as general surgery, by the American Osteopathic Board of Surgery.

Our Breast Cancer Center team also includes nurses, certified nutritionists, naturopathic providers and care managers, among others. Explore the menu below to learn more about each of our Breast Cancer Center doctors:

Accreditations

Our nationally accredited breast program has received a three-year, full accreditation by the National Accreditation Program for Breast Centers (NAPBC), a program administered by the American College of Surgeons.

A comprehensive team approach

Our Breast Cancer Center is staffed by oncology experts from a variety of disciplines, including surgical oncology, plastic and reconstructive surgery, medical oncology, radiation oncology and pathology—all under one roof. These cancer experts work closely with one another to develop multidisciplinary treatment plans tailored to each patient’s individual needs.

Each care team at the Breast Cancer Center is led by a medical oncologist and coordinated by a care manager, who provides you with test results, finds answers to your medical questions and serves as your link for questions and concerns once you return home. Your care team also may include a breast surgeon, a radiation oncologist, a radiologist, a pathologist and a plastic and reconstructive surgeon. Typically, a patient sees every clinician on his or her care team before beginning treatment, so options are discussed upfront. The clinicians then discuss the case as a team and include the patient in treatment decisions.

Genetic testing

Many breast cancer patients develop the disease because of an inherited gene mutation. Genetic testing may be recommended for certain patients, including those who are under the age of 50 or women who have a family history that indicates they may have an inherited gene mutation. The tests may also help determine whether patients have an increased risk for a second cancer.

Learn more about genetic testing at CTCA in Tulsa.

Breast cancer clinical trials

Our Breast Cancer Center conducts clinical trials as part of our commitment to providing new and innovative treatment options when possible. In delivering on this commitment, we offer carefully selected clinical trials to breast cancer patients who meet certain criteria. These trials study potential advancements in various treatment approaches, which may include genomic profiling and targeted therapies, as well as effects on HER2-positive breast cancer or other subtypes, offering some patients options that may not otherwise have been available to them. Learn more with our Clinical Trials Q&A.


Clinical trials Q&A

Who may benefit from breast cancer clinical trials?
The answer is based on a case-by-case analysis of each breast cancer patient’s situation. This is a time of rapid scientific advances in breast cancer treatment. New surgical techniques are being developed with a goal of attacking tumors while reducing the amount of trauma to healthy breast and other tissue. Meanwhile, a new generation of breast cancer therapies is designed to attack tumors that have specific genomic mutations, such as too much HER2, mTOR, CDK4 and CDK6. These new targeted treatments may be more effective and cause fewer side effects than traditional chemotherapy. But they are so specialized that only a limited subset of patients qualifies for participation. Genomic tumor testing may determine whether you are a candidate. Other factors—such as your cancer type and stage, how you have responded to past treatments and other individual considerations—may also determine whether you qualify for specific breast cancer trials.
Are they only available to breast cancer patients who have exhausted other treatment options?
Breast cancer patients may qualify to participate in a clinical trial at any stage of their treatment journey. Some patients may join a clinical trial when they first start treatment, in conjunction with standard therapy, on the chance it may offer better results. Other trials are designed for breast cancer patients who have not responded adequately to conventional treatments. Your oncologist may discuss the options and risks, and explain the various protocols involved.
How does CTCA select the breast cancer trials it offers?
At CTCA, our experts are always searching for innovative ways to treat breast cancer. Offering carefully selected clinical trials when appropriate helps us fulfill that mission. The new generation of precision drugs is generally designed to deliver more targeted, less toxic therapies. Our oncologists decide to participate as a clinical trial site only after careful consideration of the relative benefit to patients.
How do I find out whether a specific breast cancer clinical trial may benefit me?
Your oncologist and care team may recommend a trial depending on your individual needs and treatment goals. Learn more about ongoing clinical trials at CTCA. For general questions, contact an Oncology Information Specialist at 888-841-9129.

Hear from our breast cancer patients

audrey allen
Audrey Allen

At CTCA, my doctors and care team members listened. They sat down with me and put together a treatment plan that was personalized to me.

Continue reading

rhonda spinks
Rhonda Spinks

What I valued most during my treatment was the love I felt. Being treated so lovingly ... helped me look forward in a positive way.

Continue reading

cathie hogate
Cathie Hogate

At CTCA, I had the pleasure of developing a friendship with a nurse I saw at each visit. A small thing like that makes a big difference.

Continue reading

Hospitals
HOSPITALS
Cancer Types
CANCER TYPE
Our Doctors
OUR DOCTORS
INSURANCE
INSURANCE